NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-119-2007-0-CN-04 TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY CN National Stage 200680040513.9 Abandoned
NCI E-119-2007-0-JP-05 TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY JP National Stage 2008-540197 Abandoned
NCI E-119-2007-0-EP-09 TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY EP National Stage 06827682.3 Abandoned
NCI E-119-2007-0-CA-08 TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY CA National Stage 2626859 Abandoned
NCI E-119-2007-0-MX-06 TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY MX National Stage MX/A/2008/005674 Abandoned
NCI E-119-2007-0-IL-10 TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY IL National Stage 1983-01-19 Abandoned
NCI E-119-2007-0-AU-07 TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY AU National Stage 2006311475 Abandoned
NIDCR E-018-2003-0-US-02 Postnatal Stem Cells And Uses Thereof US National Stage 10/553,633 9175264 Issued PDF
NIAID E-090-1996-0-US-08 CC CHEMOKINE RECEPTOR 5 DNA, NEW ANIMAL MODELS AND THERAPEUTIC AGENTS FOR HIV INFECTION US DIV 11/594,375 7374872 Abandoned PDF
NCI E-208-2006-0-US-01 Detection And Subtyping Of Influenza Strains (including All Known Human And Avian Strains) With Genome-tiling Oligonucleotide Microarray US 60/857,695 Abandoned
NIDDK E-022-2007-0-US-01 IDENTIFICATION OF AN IRON REGULATION MECHANISM IN PATIENTS WITH BETA-THALASSEMIA US 60/864,705 Abandoned
NCI E-256-2006-0-US-01 Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs US 60/864,665 Abandoned
NCI E-226-2006-0-US-01 Synthesis And Use Of Two Protected Variants Of The 1B4M DTPA US 60/864,503 Abandoned
NIDDK E-352-2003-0-US-03 Expression Of Structural Proteins Of West Nile Virus In Insect Cells US National Stage 11/579,459 Abandoned
NIDCR E-138-1994-0-US-07 CARTILAGE-DERIVED MORPHOGENETIC PROTEINS US CON 11/592,811 Abandoned
NCI E-151-2007-2-US-13 Nucleotide Sequences Of HIV-1 Type (or Subtype) O Retrovirus Antigens US CON 11/591,678 8236324 Expired PDF
NCI E-261-2003-0-US-08 GENE-CASSETTE FOR ENHANCEMENT OF PROTEIN PRODUCTION US National Stage 11/579,419 Abandoned
NICHD E-023-2006-0-PCT-02 Method Evolved for Recognition and Testing of Age-Related Macular Degeneration (MERT-ARMD) PCT PCT PCT/US2006/042903 Expired
NICHD E-023-2006-0-EP-05 Method Evolved for Recognition and Testing of Age-Related Macular Degeneration (MERT-ARMD) EP National Stage 06836855.4 Abandoned
NCI E-227-2006-1-US-01 Prevention Of Tissue Ischemia US 60/864,153 Abandoned
NHGRI E-009-2007-0-US-01 COMPOSITIONS AND METHODS FOR PREDICTING BODY SIZE IN DOGS. US 60/856,411 Abandoned
NICHD E-023-2006-0-AU-03 Method Evolved for Recognition and Testing of Age-Related Macular Degeneration (MERT-ARMD) AU National Stage 2006311966 Abandoned
NICHD E-023-2006-0-CA-04 Method Evolved for Recognition and Testing of Age-Related Macular Degeneration (MERT-ARMD) CA National Stage 2627686 Abandoned
NCI E-333-2005-0-PCT-02 Method of Screening for Hepatocellular Carcinoma PCT PCT PCT/US2006/042591 Abandoned
NCI E-050-2007-1-US-01 Identification Of Novel Liver Cancer Biomarkers From MicroRNA Profiling US 60/855,895 Abandoned
NCI E-003-2006-0-US-03 Antibodies and Immunotoxins that Target Human Glycoprotein NMB US National Stage 12/092,228 8039593 Abandoned PDF
NCI E-003-2006-0-PCT-02 Antibodies and Immunotoxins that Target Human Glycoprotein NMB PCT PCT PCT/US2006/042735 Expired
NCI E-014-2007-0-US-01 Peptide And Peptidomimetic Inhibitors Of Smoothened Protein As Anti-neoplastic Agents US 60/855,422 Abandoned
NCI E-076-2004-0-US-03 Epitope-Enhancement of a Human CD4 HIV Epitope US National Stage 11/579,230 Abandoned
NCI E-207-2007-0-US-01 N4 Modification Of Nucleotides For Increased Stability, Oral Bioavailability, Targeted Delivery And Combination Therapy US 60/855,220 Abandoned
NIMH E-157-2006-0-US-01 Methods To Identify Patients At Risk Of Developing Adverse Advents During Treatment With Antidepressant Medication US 60/854,978 Abandoned
NIDCR E-329-2003-0-US-03 Bovine Adeno-Associated Virus (BAAV) Vector and Uses Thereof US National Stage 10/581,228 8137960 Abandoned PDF
NCI E-260-1994-2-JP-26 COMPOSITION COMPRISING A RECOMBINANT VIRUS EXPRESSING AN ANTIGEN AND A RECOMBINANT VIRUS EXPRESSING AN IMMUNOSTIMULATORY MOLECULE JP DIV 2006-291632 Expired
NCI E-009-1999-0-US-04 A Novel ATP-Binding Cassette Protein Responsible for Cytotoxin Resistance US DIV 11/588,744 Abandoned
NCI E-140-2006-0-PCT-01 A NANOPARTICLE-BASED ANTICOAGULANTg PCT PCT PCT/US2006/041838 Expired
NCI E-149-1995-0-US-03 An Epithelial Cell Specific Growth Factor, Keratinocyte Growth Factor (KGF) (as amended) US CON 11/585,862 Abandoned
NICHD E-239-2000-0-US-08 MATER-PROTEIN SPECIFIC ANTIBODIES AND METHODS OF USE US DIV 11/586,160 7531635 Abandoned PDF
NICHD E-239-2000-0-US-09 METHODS OF DETECTION OF MATER PROTEIN AUTOANTIBODIES US DIV 11/586,075 7432067 Abandoned PDF
NCI E-006-2007-0-PCT-01 Interaction of IL-27 and IL-2 for Treatment of Tumors PCT PCT PCT/US2006/041534 Abandoned
NCI E-312-2005-0-PCT-02 Immunogenic Peptides and Methods of Use for Treating and Preventing Cancer PCT PCT PCT/US2006/041462 Expired
NINDS E-014-2006-1-US-01 In-vitro Assay To Screen For Enhancement Of Mutated Alpha-galactosidase A (GLA) By Small Molecules Chaperones For Fabry Disease US 60/853,631 Abandoned
NIDCR E-008-2006-0-PCT-03 Single Nucleotide Polymorphisms In GCH1 For The Diagnosis And Prognosis Of Pain PCT PCT PCT/US2006/041087 Expired
NHLBI E-014-2004-0-US-07 Monoclonal Antibody That Specifically Binds Stem Cells and Its Use US National Stage 11/578,891 Abandoned
NIDCR E-008-2006-0-US-02 DIAGNOSTIC METHODS FOR PAIN SENSITIVITY AND CHRONICITY AND FOR TETRAHYDROBIOPTERIN-RELATED DISORDERS US National Stage 11/584,449 Abandoned
NIDCR E-008-2006-0-EP-04 DIAGNOSTIC METHODS FOR PAIN SENSITIVITY AND CHRONICITY AND FOR TETRAHYDROBIOPTERIN-RELATED DISORDERS EP National Stage 06836432.2 Abandoned
NIDCR E-008-2006-0-CA-07 Single Nucleotide Polymorphisms In GCH1 For The Diagnosis And Prognosis Of Pain CA National Stage 2630030 Abandoned
NIDCR E-008-2006-0-AU-06 DIAGNOSTIC METHODS FOR PAIN SENSITIVITY AND CHRONICITY AND FOR TETRAHYDROBIOPTERIN-RELATED DISORDERS AU National Stage 2006323157 Abandoned
NCI E-244-2005-1-AU-05 In Situ Assembling Of Protein Microarrays AU National Stage 2006304659 Abandoned
NCI E-244-2005-1-CH-06 In Situ Assembling Of Protein Microarrays CH EP 06836399.3 Abandoned
NCI E-244-2005-1-GB-09 In Situ Assembling Of Protein Microarrays GB EP 06836399.3 Abandoned